Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-FCGRT, SYNT-001 Vector   (CAT#: GTVCR-WQ2534MR)

This product GTVCR-WQ2534MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting FCGRT. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Chimeric
RefSeq NM_000484.4
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 351
UniProt ID P05067
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-FCGRT, SYNT-001 Vector (GTVCR-WQ2534MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1035MR IVTScrip™ pT7-VEE-mRNA-Anti-IGF1R, CP-751871 Vector Vector CP-751871
GTVCR-WQ1286MR IVTScrip™ pSP6-VEE-mRNA-Anti-TNFRSF10B, GEN-1029 Vector Vector GEN-1029
GTVCR-WQ835MR IVTScrip™ pT7-VEE-mRNA-Anti-GP, c2G4-N Vector Vector c2G4-N
GTVCR-WQ1854MR IVTScrip™ pSP6-VEE-mRNA-Anti-EGFR&LGR5, MCLA-158 Vector Vector MCLA-158
GTVCR-WQ1670MR IVTScrip™ pSP6-VEE-mRNA-Anti-hly, KBSA301 Vector Vector KBSA301
GTVCR-WQ70MR IVTScrip™ pSP6-VEE-mRNA-Anti-ALB&IL6R, 20A11-9mer-ALB11 Vector Vector 20A11-9mer-ALB11
GTVCR-WQ2410MR IVTScrip™ pSP6-VEE-mRNA-Anti-IFNA1, RhuMAB IFNalpha Vector Vector RhuMAB IFNalpha
GTVCR-WQ1568MR IVTScrip™ pT7-VEE-mRNA-Anti-PDCD1, INCMGA-00012 Vector Vector INCMGA-00012
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.